Champignon Brands Changes Name to Braxia Scientific to Reflect the Integration...

Psychedelic Bulletin: MindMed Uplists to Nasdaq; Cybin Targets Alcoholism; COMPASS Announces...

Ketanserin’s Contributions to Psychedelic Research

Should Society Legalize Psychedelics? A Breakdown of the Intelligence Squared Debate

PTSF57 – New Compounds, Psychedelic Business, and Neurogenesis

COMPASS Pathways announces pricing of public offering

Numinus Wellness Q2 2021 Results Highlighted by $17.25 Million Financing, Mindspace...

Op-Ed: Re-evaluating the Results of the Recent Trial of Psilocybin vs...

Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation

Tryp Therapeutics Announces Q2 2021 Financial Results

Load more